Disruption of the GluA2/GAPDH complex using TAT-GluA2NT1-3-2 peptide protects against AMPAR-mediated excitotoxicity after epilepsy. [electronic resource]
Producer: 20190405Description: 432-439 p. digitalISSN:- 1473-558X
- Animals
- Anticonvulsants -- pharmacology
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Epilepsy -- drug therapy
- Glyceraldehyde-3-Phosphate Dehydrogenases -- metabolism
- Hippocampus -- drug effects
- Male
- Neurons -- drug effects
- Neuroprotective Agents -- pharmacology
- Peptides -- pharmacology
- Pilocarpine
- Rats, Wistar
- Receptors, AMPA -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.